1887

Abstract

Extra-intestinal pathogenic (ExPEC) ST1193, a globally emergent fluoroquinolone-resistant clone, has become an important cause of bloodstream infections (BSIs) associated with significant morbidity and mortality. Previous studies have reported the emergence of fluoroquinolone-resistant ExPEC ST1193 in Vietnam; however, limited data exist regarding the genetic structure, antimicrobial resistance (AMR) determinants and transmission dynamics of this pandemic clone. Here, we performed genomic and phylogenetic analyses of 46 ST1193 isolates obtained from BSIs and healthy individuals in Ho Chi Minh City, Vietnam, to investigate the pathogen population structure, molecular mechanisms of AMR and potential transmission patterns. We further examined the phylogenetic structure of ST1193 isolates in a global context. We found that the endemic ST1193 population was heterogeneous and highly dynamic, largely driven by multiple strain importations. Several well-supported phylogenetic clusters (C1–C6) were identified and associated with distinct variants, including (C1–C3, C5), (C4) and (C6). Most ST1193 isolates were multidrug-resistant and carried an extensive array of AMR genes. ST1193 isolates also exhibited the ability to acquire further resistance while circulating in Vietnam. There were phylogenetic links between ST1193 isolates from BSIs and healthy individuals, suggesting these organisms may both establish long-term colonization in the human intestinal tract and induce infections. Our study uncovers factors shaping the population structure and transmission dynamics of multidrug-resistant ST1193 in Vietnam, and highlights the urgent need for local One Health genomic surveillance to capture new emerging ExPEC clones and to better understand the origins and transmission patterns of these pathogens.

Funding
This study was supported by the:
  • Wellcome Trust (Award 215515/Z/19/Z)
    • Principle Award Recipient: StephenBaker
  • Oak Foundation (Award OCAY-15-547)
    • Principle Award Recipient: DuyThanh Pham
  • This is an open-access article distributed under the terms of the Creative Commons Attribution License.
Loading

Article metrics loading...

/content/journal/mgen/10.1099/mgen.0.000733
2021-12-14
2024-03-19
Loading full text...

Full text loading...

/deliver/fulltext/mgen/7/12/mgen000733.html?itemId=/content/journal/mgen/10.1099/mgen.0.000733&mimeType=html&fmt=ahah

References

  1. Fani F, Leprohon P, Zhanel GG, Bergeron MG, Ouellette M. Genomic analyses of DNA transformation and penicillin resistance in Streptococcus pneumoniae clinical isolates. Antimicrob Agents Chemother 2014; 58:1397–1403 [View Article] [PubMed]
    [Google Scholar]
  2. Kim JY, Lautenbach E, Chu J, Goyal M, Nachamkin I et al. Fluoroquinolone resistance in pediatric bloodstream infections because of Escherichia coli and Klebsiella species. Am J Infect Control 2008; 36:70–73 [View Article] [PubMed]
    [Google Scholar]
  3. Kanoksil M, Jatapai A, Peacock SJ, Limmathurotsakul D. Epidemiology, microbiology and mortality associated with community-acquired bacteremia in northeast Thailand: a multicenter surveillance study. PLoS One 2013; 8:e54714 [View Article] [PubMed]
    [Google Scholar]
  4. Le T, Wolbers M, Chi NH, Quang VM, Chinh NT et al. Epidemiology, seasonality, and predictors of outcome of AIDS-associated Penicillium marneffei infection in Ho Chi Minh City, Viet Nam. Clin Infect Dis 2011; 52:945–952 [View Article] [PubMed]
    [Google Scholar]
  5. Nguyen PHL. Defining the Aetiology and Antimicrobial Susceptibility Patterns of the Predominant Bacteria Associated with Bloodstream Infections at the Hospital for Tropical Diseases in Ho Chi Minh City, Vietnam The Open University; UK: 2018
    [Google Scholar]
  6. Reddy EA, Shaw AV, Crump JA. Community-acquired bloodstream infections in Africa: a systematic review and meta-analysis. Lancet Infect Dis 2010; 10:417–432 [View Article] [PubMed]
    [Google Scholar]
  7. Goto M, Al-Hasan MN. Overall burden of bloodstream infection and nosocomial bloodstream infection in North America and Europe. Clin Microbiol Infect 2013; 19:501–509 [View Article] [PubMed]
    [Google Scholar]
  8. Fleischmann C, Scherag A, Adhikari NKJ, Hartog CS, Tsaganos T et al. Assessment of global incidence and mortality of hospital-treated sepsis. current estimates and limitations. Am J Respir Crit Care Med 2016; 193:259–272 [View Article] [PubMed]
    [Google Scholar]
  9. Zaidi AKM, Thaver D, Ali SA, Khan TA. Pathogens associated with sepsis in newborns and young infants in developing countries. Pediatr Infect Dis J 2009; 28:S10–S18 [View Article]
    [Google Scholar]
  10. Diekema DJ, Hsueh P-R, Mendes RE, Pfaller MA, Rolston KV et al. The microbiology of bloodstream infection: 20-year trends from the SENTRY antimicrobial surveillance program. Antimicrob Agents Chemother 2019; 63:e00355-19. [View Article] [PubMed]
    [Google Scholar]
  11. Laupland KB, Church DL. Population-based epidemiology and microbiology of community-onset bloodstream infections. Clin Microbiol Rev 2014; 27:647–664 [View Article] [PubMed]
    [Google Scholar]
  12. Magiorakos A-P, Srinivasan A, Carey RB, Carmeli Y, Falagas ME et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: An international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect 2012; 18:268–281 [View Article] [PubMed]
    [Google Scholar]
  13. Rodríguez-Baño J, Picón E, Gijón P, Hernández JR, Ruíz M et al. Community-onset bacteremia due to extended-spectrum beta-lactamase-producing Escherichia coli: risk factors and prognosis. Clin Infect Dis 2010; 50:40–48 [View Article] [PubMed]
    [Google Scholar]
  14. Tumbarello M, Spanu T, Di Bidino R, Marchetti M, Ruggeri M et al. Costs of bloodstream infections caused by Escherichia coli and influence of extended-spectrum-beta-lactamase production and inadequate initial antibiotic therapy. Antimicrob Agents Chemother 2010; 54:4085–4091 [View Article] [PubMed]
    [Google Scholar]
  15. Trecarichi EM, Tumbarello M, Spanu T, Caira M, Fianchi L et al. Incidence and clinical impact of extended-spectrum-beta-lactamase (ESBL) production and fluoroquinolone resistance in bloodstream infections caused by Escherichia coli in patients with hematological malignancies. J Infect 2009; 58:299–307 [View Article] [PubMed]
    [Google Scholar]
  16. Riley LW. Pandemic lineages of extraintestinal pathogenic Escherichia coli. Clin Microbiol Infect 201420380–390 [View Article] [PubMed]
    [Google Scholar]
  17. Manges AR, Geum HM, Guo A, Edens TJ, Fibke CD et al. Global extraintestinal pathogenic Escherichia coli (Expec) lineages. Clin Microbiol Rev 2019; 32:e00135-18. [View Article] [PubMed]
    [Google Scholar]
  18. Tchesnokova VL, Rechkina E, Larson L, Ferrier K, Weaver JL et al. Rapid and extensive expansion in the United States of a new multidrug-resistant Escherichia coli clonal group, sequence type 1193. Clin Infect Dis 2019; 68:334–337 [View Article]
    [Google Scholar]
  19. Holland MS, Nobrega D, Peirano G, Naugler C, Church DL et al. Molecular epidemiology of Escherichia coli causing bloodstream infections in a centralized Canadian region: a population-based surveillance study. Clin Microbiol Infect 2020; 26:1554 [View Article] [PubMed]
    [Google Scholar]
  20. Wu J, Lan F, Lu Y, He Q, Li B. Molecular characteristics of ST1193 clone among phylogenetic group B2 Non-ST131 fluoroquinolone-resistant Escherichia coli. Front Microbiol 2017; 8:2294. [View Article] [PubMed]
    [Google Scholar]
  21. Johnson TJ, Elnekave E, Miller EA, Munoz-Aguayo J, Flores Figueroa C et al. Phylogenomic analysis of extraintestinal pathogenic Escherichia coli Sequence Type 1193, an emerging multidrug-resistant clonal group. Antimicrob Agents Chemother 2019; 63:e01913-18. [View Article] [PubMed]
    [Google Scholar]
  22. Nguyen MN, Hoang HTT, Xavier BB, Lammens C, Le HT et al. Prospective One Health genetic surveillance in Vietnam identifies distinct blaCTX-M-harbouring Escherichia coli in food-chain and human-derived samples. Clin Microbiol Infect 2021; 27:1515 [View Article] [PubMed]
    [Google Scholar]
  23. Platell JL, Trott DJ, Johnson JR, Heisig P, Heisig A et al. Prominence of an O75 clonal group (clonal complex 14) among non-st131 fluoroquinolone-resistant Escherichia coli causing extraintestinal infections in humans and dogs in Australia. Antimicrob Agents Chemother 2012; 56:3898–3904 [View Article] [PubMed]
    [Google Scholar]
  24. Vu TVD, Do TTN, Rydell U, Nilsson LE, Olson L et al. Antimicrobial susceptibility testing and antibiotic consumption results from 16 hospitals in Viet Nam: The VINARES project 2012–2013. J Global Antimicrobial Resistance 2019; 18:269–278 [View Article]
    [Google Scholar]
  25. Toan ND, Darton TC, Boinett CJ, Campbell JI, Karkey A et al. Clinical features, antimicrobial susceptibility patterns and genomics of bacteria causing neonatal sepsis in a children’s hospital in Vietnam: protocol for a prospective observational study. BMJ Open 2018; 8:e019611. [View Article] [PubMed]
    [Google Scholar]
  26. Thompson CN, Anders KL, Nhi LTQ, Tuyen HT, Van Minh P et al. A cohort study to define the age-specific incidence and risk factors of Shigella diarrhoeal infections in Vietnamese children: A study protocol. BMC Public Health 2014; 14:1289 [View Article] [PubMed]
    [Google Scholar]
  27. Duong VT, Tuyen HT, Van Minh P, Campbell JI, Phuc HL et al. No Clinical benefit of empirical antimicrobial therapy for pediatric diarrhea in a high-usage, high-resistance setting. Clin Infect Dis 2018; 66:504–511 [View Article] [PubMed]
    [Google Scholar]
  28. The Clinical and Laboratory Standards Institute Performance Standards for Antimicrobial Susceptibility Testing CLSI Supplement M100S 2016
    [Google Scholar]
  29. Li H, Handsaker B, Wysoker A, Fennell T, Ruan J et al. The Sequence Alignment/Map format and SAMtools. Bioinformatics 2009; 25:2078–2079 [View Article] [PubMed]
    [Google Scholar]
  30. Holt KE, Baker S, Weill F-X, Holmes EC, Kitchen A et al. Shigella sonnei genome sequencing and phylogenetic analysis indicate recent global dissemination from Europe. Nat Genet 2012; 44:1056–1059 [View Article] [PubMed]
    [Google Scholar]
  31. Wyres KL, Wick RR, Gorrie C, Jenney A, Follador R et al. Identification of Klebsiella capsule synthesis loci from whole genome data. Microb Genom 2016; 2:e000102 [View Article] [PubMed]
    [Google Scholar]
  32. Croucher NJ, Page AJ, Connor TR, Delaney AJ, Keane JA et al. Rapid phylogenetic analysis of large samples of recombinant bacterial whole genome sequences using Gubbins. Nucleic Acids Res 2015; 43:e15 [View Article] [PubMed]
    [Google Scholar]
  33. Stamatakis A. RAxML version 8: a tool for phylogenetic analysis and post-analysis of large phylogenies. Bioinformatics 2014; 30:1312–1313 [View Article] [PubMed]
    [Google Scholar]
  34. Letunic I, Bork P. Interactive Tree Of Life (iTOL): An online tool for phylogenetic tree display and annotation. Bioinformatics 2007; 23:127–128 [View Article] [PubMed]
    [Google Scholar]
  35. Inouye M, Dashnow H, Raven L-A, Schultz MB, Pope BJ et al. SRST2: Rapid genomic surveillance for public health and hospital microbiology labs. Genome Med 2014; 6:90. [View Article] [PubMed]
    [Google Scholar]
  36. Gupta SK, Padmanabhan BR, Diene SM, Lopez-Rojas R, Kempf M et al. ARG-annot, a new bioinformatic tool to discover antibiotic resistance genes in bacterial genomes. Antimicrob Agents Chemother 2014; 58:212–220 [View Article] [PubMed]
    [Google Scholar]
  37. Carattoli A, Zankari E, García-Fernández A, Voldby Larsen M, Lund O et al. In Silico detection and typing of plasmids using plasmidfinder and plasmid multilocus sequence typing. Antimicrob Agents Chemother 2014; 58:3895–3903 [View Article] [PubMed]
    [Google Scholar]
  38. Ingle DJ, Valcanis M, Kuzevski A, Tauschek M, Inouye M et al. In silico serotyping of E. coli from short read data identifies limited novel o-loci but extensive diversity of O:H serotype combinations within and between pathogenic lineages. Microb Genom 2016; 2:e000064 [View Article] [PubMed]
    [Google Scholar]
  39. Wick RR, Judd LM, Gorrie CL, Holt KE, Phillippy AM. Unicycler: Resolving bacterial genome assemblies from short and long sequencing reads. PLoS Comput Biol 2017; 13:e1005595 [View Article]
    [Google Scholar]
  40. Alikhan NF, Petty NK, Ben Zakour NL, Beatson SA. BLAST Ring Image Generator (BRIG): Simple prokaryote genome comparisons. BMC Genomics 2011; 12:402 [View Article] [PubMed]
    [Google Scholar]
  41. Dahbi G, Mora A, Mamani R, López C, Alonso MP et al. Molecular epidemiology and virulence of Escherichia coli O16:H5-ST131: comparison with H30 and H30-Rx subclones of O25b:H4-ST131. Int J Med Microbiol 2014; 304:1247–1257 [View Article] [PubMed]
    [Google Scholar]
  42. Blanco J, Mora A, Mamani R, López C, Blanco M et al. Four main virotypes among extended-spectrum-β-lactamase-producing isolates of Escherichia coli O25b:H4-B2-ST131: Bacterial, epidemiological, and clinical characteristics. J Clin Microbiol 2013; 51:3358–3367 [View Article] [PubMed]
    [Google Scholar]
  43. Pataki , Matamoros S, van der Putten BCL, Remondini D, Giampieri E et al. Understanding and predicting ciprofloxacin minimum inhibitory concentration in Escherichia coli with machine learning. Sci Rep 2020; 10:1–9 [View Article] [PubMed]
    [Google Scholar]
  44. Tchesnokova V, Riddell K, Scholes D, Johnson JR, Sokurenko EV. The uropathogenic Escherichia coli subclone sequence type 131-H30 is responsible for most antibiotic prescription errors at an urgent care clinic. Clin Infect Dis 2019; 68:781–787 [View Article] [PubMed]
    [Google Scholar]
  45. Roer L, Hansen F, Thomsen MCF, Knudsen JD, Hansen DS et al. WGS-based surveillance of third-generation cephalosporin-resistant Escherichia coli from bloodstream infections in Denmark. J Antimicrob Chemother 2017; 72:1922–1929 [View Article] [PubMed]
    [Google Scholar]
  46. Heng ST, Chen SL, Wong JGX, Lye DC, Ng TM. No association between resistance mutations, empiric antibiotic, and mortality in ceftriaxone-resistant Escherichia coli and Klebsiella pneumoniae bacteremia. Sci Rep 2018; 8:1–10 [View Article]
    [Google Scholar]
  47. Matsumura Y, Pitout JDD, Gomi R, Matsuda T, Noguchi T et al. Global Escherichia coli sequence type 131 clade with blaCTX-M-27 gene. Emerg Infect Dis 2016; 22:1900–1907 [View Article] [PubMed]
    [Google Scholar]
  48. Fernandes MR, Sellera FP, Cunha MPV, Lopes R, Cerdeira L et al. Emergence of CTX-M-27-producing Escherichia coli of ST131 and clade C1-M27 in an impacted ecosystem with international maritime traffic in South America. J Antimicrob Chemother 2020; 75:1647–1649 [View Article]
    [Google Scholar]
  49. Thanh Duy P, Thi Nguyen TN, Vu Thuy D, Chung The H, Alcock F et al. Commensal Escherichia coli are a reservoir for the transfer of XDR plasmids into epidemic fluoroquinolone-resistant Shigella sonnei. Nat Microbiol 2020; 5:256–264 [View Article] [PubMed]
    [Google Scholar]
  50. Manges AR, Johnson JR, Mulvey MA, Stapleton AE, Klumpp DJ. Reservoirs of extraintestinal pathogenic Escherichia coli. Microbiol Spectr 2015; 3:1–12 [View Article]
    [Google Scholar]
  51. Sarowska J, Futoma-Koloch B, Jama-Kmiecik A, Frej-Madrzak M, Ksiazczyk M et al. Virulence factors, prevalence and potential transmission of extraintestinal pathogenic Escherichia coli isolated from different sources: Recent reports. Gut Pathog 2019; 11:1–16 [View Article] [PubMed]
    [Google Scholar]
  52. Mukerji S, Stegger M, Truswell AV, Laird T, Jordan D et al. Resistance to critically important antimicrobials in Australian silver gulls (Chroicocephalus novaehollandiae) and evidence of anthropogenic origins. J Antimicrob Chemother 2019; 74:2566–2574 [View Article] [PubMed]
    [Google Scholar]
  53. Bergeron CR, Prussing C, Boerlin P, Daignault D, Dutil L et al. Chicken as reservoir for extraintestinal pathogenic Escherichia coli in Humans, Canada. Emerg Infect Dis 2012; 18:415–421 [View Article] [PubMed]
    [Google Scholar]
  54. Day MJ, Hopkins KL, Wareham DW, Toleman MA, Elviss N et al. Extended-spectrum β-lactamase-producing Escherichia coli in human-derived and foodchain-derived samples from England, Wales, and Scotland: an epidemiological surveillance and typing study. Lancet Infect Dis 2019; 19:1325–1335 [View Article] [PubMed]
    [Google Scholar]
  55. Nguyen VT, Jamrozy D, Matamoros S, Carrique-Mas JJ, Ho HM et al. Limited contribution of non-intensive chicken farming to ESBL-producing Escherichia coli colonization in humans in Vietnam: An epidemiological and genomic analysis. J Antimicrob Chemother 2019; 74:561–570 [View Article] [PubMed]
    [Google Scholar]
  56. Ueda S, Ngan BTK, Huong BTM, Hirai I, Tuyen LD et al. Limited transmission of bla(CTX-M-9)-type-positive Escherichia coli between humans and poultry in Vietnam. Antimicrob Agents Chemother 2015; 59:3574–3577 [View Article] [PubMed]
    [Google Scholar]
  57. Dat VQ, Vu HN, Nguyen The H, Nguyen HT, Hoang LB et al. Bacterial bloodstream infections in a tertiary infectious diseases hospital in Northern Vietnam: Aetiology, drug resistance, and treatment outcome. BMC Infect Dis 2017; 17:493. [View Article] [PubMed]
    [Google Scholar]
  58. Nguyen DP, Nguyen TAD, Le TH, Tran NMD, Ngo TP et al. Dissemination of Extended-Spectrum β-Lactamase- and AmpC β-Lactamase-Producing Escherichia coli within the Food Distribution System of Ho Chi Minh City, Vietnam. Biomed Res Int 2016; 2016:8182096. [View Article] [PubMed]
    [Google Scholar]
  59. Kantele A, Kuenzli E, Dunn SJ, Dance DAB, Newton PN et al. Dynamics of intestinal multidrug-resistant bacteria colonisation contracted by visitors to a high-endemic setting: a prospective, daily, real-time sampling study. Lancet Microbe 2021; 2:e151–e158 [View Article] [PubMed]
    [Google Scholar]
  60. Frost I, Van Boeckel TP, Pires J, Craig J, Laxminarayan R. Global geographic trends in antimicrobial resistance: The role of international travel. J Travel Med 2019; 26:taz036. [View Article] [PubMed]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/mgen/10.1099/mgen.0.000733
Loading
/content/journal/mgen/10.1099/mgen.0.000733
Loading

Data & Media loading...

Supplements

Supplementary material 1

EXCEL

Supplementary material 2

EXCEL
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error